Chinese Startups, US Biotechs Price IPOs Raising $121M
By Darcy Reddan · November 8, 2019, 5:26 PM EST
Two Chinese startups, a U.S. medical device company and a brain-cancer focused biotechnology company raised a combined $121 million in initial public offerings that began trading Friday, as what had been...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login